Legislation

Title: Health Insurance - Prescription Insulin Drugs - Limits on Copayment and Coinsurance
Sponsored by: Delegates Cox, Boteler, Hornberger, McComas, and Thiam
Status: In the House - Hearing 3/03 at 1:30 p.m.
Analysis: Fiscal and Policy Note

Synopsis

Requiring health insurance carriers to limit the amount a covered individual is required to pay in copayments or coinsurance for a covered prescription insulin drug to $30 for a 30-day supply; and requiring the Prescription Drug Affordability Board to conduct a certain cost review of prescription insulin drug products.

Committees

Original:: Health and Government Operations Click to view Recorded Media

Committee Testimony

Witness List

Details

Bill File Type: Regular

Effective Date(s): June 1, 2022

History

Legislation History
Chamber House Calendar Date 2/11/2022 Legislative Date 2/11/2022 Action First Reading Health and Government Operations Proceedings
Chamber House Calendar Date 2/14/2022 Legislative Date 2/14/2022 Action Hearing 3/03 at 1:30 p.m. Proceedings
Chamber Calendar Date Legislative Date Action Text - First - Health Insurance - Prescription Insulin Drugs - Limits on Copayment and Coinsurance Proceedings

Chamber	Calendar Date	Legislative Date	Action
House	2/11/2022	2/11/2022	First Reading Health and Government Operations
House	2/14/2022	2/14/2022	Hearing 3/03 at 1:30 p.m.
			Text - First - Health Insurance - Prescription Insulin Drugs - Limits on Copayment and Coinsurance

File Code

Subjects

Statutes